Emerging pipeline drugs for hepatitis B infection

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.16, Iss.4, 2011-12, pp. : 713-729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for hepatitis B

By Zoulim Fabien

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 199-217

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for hepatitis C

By Soriano Vincent Madejon Antonio Vispo Eugenia Labarga Pablo Garcia-Samaniego Javier Martin-Carbonero Luz Sheldon Julie Bottecchia Marcelle Tuma Paula Barreiro Pablo

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 1-19

Informa Healthcare

Access to resources Recommend Favorite

Drugs in Development for Hepatitis B

By Buti Maria Esteban Rafael

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1451-1460

Adis International

Access to resources Recommend Favorite

Emerging treatments in chronic hepatitis B

By Hadziyannis Stephanos J Papatheodoridis George V

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 207-221

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for a Phantom Menace: Emerging Drugs for Hepatitis C

By Adis International Limited

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 3, 2006-01 ,pp. : 8-13

Adis International

Access to resources Recommend Favorite